VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VRTX

<< 前へ 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/06/09	01 : 35	TipRanks	Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Aldeyra Therapeutics (ALDX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/08	21 : 00	Business Wire	Vertex Announces Inaxaplin (VX-147) Granted Breakthrough Therapy Designation by U.S. FDA and Priority Medicines (PRIME) Designation by the EMA	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/07	20 : 14	Business Wire	Vertex présente de nouvelles données sur l'essai clinique de Phase 1 du VX-880 dans le cadre des 82e sessions scientifiques de l'American Diabetes Association	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/07	20 : 14	Business Wire	Vertex präsentiert neue Daten aus der klinischen Phase-1/2-Studie zu VX-880 bei den 82. Scientific Sessions der American Diabetes Association	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/07	19 : 25	TipRanks	Analysts Are Bullish on Top Healthcare Stocks: Veru (VERU), Achieve Life Sciences (ACHV)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/06	23 : 00	Business Wire	Vertex Presents New Data from VX-880 Phase 1/2 Clinical Trial at the American Diabetes Association 82nd Scientific Sessions	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/03	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/06/02	23 : 05	Business Wire	Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001™ at the 2022 Annual European Hematology Association (EHA) Congress	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/31	22 : 05	TipRanks	Analysts Conflicted on These Healthcare Names: Nektar Therapeutics (NKTR) and Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/31	21 : 00	Business Wire	Vertex to Present New Data on VX-880 Clinical Trial at 82nd American Diabetes Association Annual Conference	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/26	11 : 56	TipRanks	Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/23	23 : 08	Dow Jones News	Catalyst Biosciences Shares Soar After Complement Portfolio Sale	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/23	21 : 42	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/23	21 : 30	GlobeNewswire Inc.	Catalyst Biosciences Sells Complement Portfolio for $60 Million	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/20	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/19	05 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/19	05 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/19	05 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/19	05 : 09	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/19	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/18	23 : 30	Business Wire	Suketu Upadhyay Elected to Vertex Board of Directors	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/17	19 : 45	Business Wire	Vertex Announces Further Expansion in the Boston Seaport at Dedication of the Jeffrey Leiden Center for Cell and Genetic Therapies	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/17	19 : 40	Business Wire	Vertex Announces $50 Million Commitment to Health Equity With Three Initial Grants	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/10	00 : 17	TipRanks	Vertex Pharmaceuticals (VRTX) Gets a Buy Rating from Evercore ISI	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/07	10 : 19	TipRanks	Barclays Maintains Their Buy Rating on Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/07	00 : 25	TipRanks	Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS) and Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/06	19 : 55	TipRanks	Needham Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/06	19 : 28	TipRanks	Vertex Pharmaceuticals (VRTX) Received its Third Buy in a Row	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/06	05 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2022/05/06	05 : 01	Business Wire	Vertex Reports First Quarter 2022 Financial Results	NASDAQ:VRTX	Vertex Pharmaceuticals Inc